Bioscrip, Alere, and Tetrapharmeuticals Top Health Holdings: Fund Manager
Gabelli Focus Five Fund Manager Dan Miller says BioScrip (BIOS), Alere (ALR), and Tetraphase Pharmaceuticals (TTPH) are his three top health care picks.
Gabelli Focus Five Fund Manager Dan Miller says BioScrip (BIOS), Alere (ALR), and Tetraphase Pharmaceuticals (TTPH) are his three top health care picks. Miller tells TheStreet's Rhonda Schaffler that he's built a big position in BioScrip over the last few weeks. He says the stock is a bargain and Ebitda can double this year. He also says BioScrip could be an acquisition target for a company like CVS. Miller is also a fan of diagnostics equipment company Alere and says it is undervalued. Tetraphase Pharmaceuticals is another one of Miller's holdings. He sees strong revenue growth in that name going forward.









